GlassScriptPhysician profile
Betsy B Beers
NPI 1275628562
$5,855.02
in general payments reported to CMS, 2019-2025
38 companies · $1,202 in 2025
The $1,202 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,244 · 2020: $260 · 2021: $619 · 2022: $972 · 2023: $747 · 2024: $813 · 2025: $1,202.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,666 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,665.86 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $911.35 | 2019-2025 | Rinvoq, Skyrizi |
| Janssen Biotech, INC. | $587.56 | 2019-2025 | Tremfya |
| Regeneron Healthcare Solutions, INC. | $445.96 | 2019-2025 | Dupixent, Libtayo |
| Novartis Pharmaceuticals Corporation | $405.73 | 2019-2025 | |
| Lilly USA, LLC | $374.53 | 2019-2025 | Taltz, Ebglyss, Olumiant |
| Sun Pharmaceutical Industries INC. | $344.51 | 2019-2025 | Odomzo, Blu-U, Ilumya |
| Leo Pharma INC. | $304.99 | 2019-2025 | Adbry, Anzupgo |
| Galderma Laboratories, L.P. | $274.46 | 2019-2025 | Nemluvio, Aklief, Oracea |
| Genzyme Corporation | $253.42 | 2020-2025 | |
| Smith+Nephew, INC. | $177.25 | 2019-2023 | Collagenase Santyl |
| Genentech USA, INC. | $173.28 | 2019-2023 | Erivedge |
| Incyte Corporation | $140.48 | 2021-2025 | Opzelura |
| Ucb, INC. | $134.11 | 2019-2025 | Bimzelx |
| Mayne Pharma Commercial LLC | $133.74 | 2023-2024 | |
| Pfizer INC. | $122.06 | 2019-2025 |
Show all 38 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Betsy Beers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.